Healthcare  Name:  Sector: Upstate Healthcare  Summary: Develops the most innovative reagents, technology platforms and services based on cell signaling for accelerating life science research and drug discovery.  Stage of Initial  Investment: Venture  Liquidity: Acquired by Serologicals Corp (Nasdaq: SERO)
	Copyright ©2009 Rho Capital Partners, Inc.